Last reviewed · How we verify
NCT03009773: SYNCOMOT
The Multitasking Rehabilitation She Enhanced Walking Speed Compared to the Simple Post Stroke Rehabilitation Task (AVC)?
NA trial testing rehabilitation multitasking walking. in Subacute Stroke in 300 participants. Status unknown.
10 May 2023
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire, Amiens |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 300 |
| Start date | 11 April 2017 |
| Primary completion | 10 May 2023 |
| Estimated completion | 10 May 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- rehabilitation multitasking walking.
- Traditional walking rehabilitation
Conditions studied
- Subacute Stroke — all drugs for Subacute Stroke →
Sponsor
Centre Hospitalier Universitaire, Amiens
Who can join
Adults 18 to 90, any sex, with Subacute Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Stroke is the leading cause of severe disability in adults. The first cause of alterations in the quality of life and autonomy in these patients are disorders of walking and the balance. They are the leading cause of falls responsible for important medical, surgical and economic complications as well as a reactionary social isolation. The techniques of rehabilitation of walking to the subacute phase of a stroke are usually based on automatic walking.Off walking is a complex activity usually performed in everyday life in association with multiple tasks. It is therefore interesting to re-educate walking in dual task or even in multitasking.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Dual-task versus single-task gait rehabilitation after stroke: the protocol of the cognitive-motor synergy multicenter, randomized, controlled superiority trial (SYNCOMOT).
Tasseel-Ponche S, Roussel M, Toba MN, Sader T, et al · · 2023 · cited 6× · PMID 36890548 · DOI 10.1186/s13063-023-07138-x
Verify or expand the search:
- PubMed search for NCT03009773
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Subacute Stroke
Currently open trials in the same condition.
- NCT07469163 — Phase I Split-Belt Treadmill Dosing for Subacute Stroke · Phase 1 · recruiting
- NCT07236216 — Effects of tES Combined With CMDT Gait Training on Cognition, Cortical Activity, Spinal Motoneuron Excitability and Moto · NA · recruiting
- NCT07353203 — Safety and Efficacy of Hip Assist Powered Exoskeleton for Gait Training in Patients With Late Subacute and Chronic Strok · NA · recruiting
- NCT06752707 — MiGo Tracker Remote Monitoring of Home Exercise After Stroke · NA · recruiting
- NCT06972355 — Efficacy of Treadmill Walking With Hidden Vision for Rehabilitation in the Subacute Phase of Stroke · NA · recruiting
Other Centre Hospitalier Universitaire, Amiens trials
Trials by the same sponsor.
- NCT07354568 — Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock · recruiting
- NCT07071662 — Induction of Labor in Breech Presentation · completed
- NCT06909487 — Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respec · completed
- NCT07037719 — Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE) · recruiting
- NCT06996145 — Study of the Isometry of the Anterior Cruciate Ligament From the Center of the Native MRI Insertion Reported on Dynamic · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03009773 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire, Amiens
- Last refreshed: 14 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03009773.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing